USPTO Memo Addresses Eligibility of Method-of-Treatment Claims in View of Federal Circuit Decision
Additional Discovery of Clinical Trial Data in Inter Partes Review
Strategic Use of a Reissue Application in the Context of an Inter Partes Review (IPR) Proceeding
Federal Circuit Splits on Approach to Analyzing Graham Factors
A Cautionary Tale: IPR Petition Denied Based on Third-Party Submission
PTAB Grants Discovery to Underlying Test Data
Subscribe: Subscribe via RSS
Blogs
Firm/Org